A PHASE 2A,RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF MT-3921 IN SUBJECTS WITH ACUTE TRAUMATIC CERVICAL SPINAL CORD INJURY
- Registry ID
- MT-3921-A01
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA INC
- Last update
- 2021-02-24
Conditions
- CERVICAL SPINAL CORD INJURY
View on source registry